These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1573833)

  • 21. Administration of IgG Fc fragments prevents glomerular injury in experimental immune complex nephritis.
    Gómez-Guerrero C; Duque N; Casado MT; Pastor C; Blanco J; Mampaso F; Vivanco F; Egido J
    J Immunol; 2000 Feb; 164(4):2092-101. PubMed ID: 10657663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Asymptomatic glomerulonephritis].
    Osawa G; Hashimoto J; Hirano H; Okamoto M; Shindo T; Yoneda M; Matsutani T
    Nihon Rinsho; 1984 Jun; 42(6):1334-8. PubMed ID: 6481996
    [No Abstract]   [Full Text] [Related]  

  • 23. Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis.
    Barnes JL; Hastings RR; De la Garza MA
    Am J Pathol; 1994 Sep; 145(3):585-97. PubMed ID: 8080041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-complement interactions in mesangial proliferative nephritis in the rat.
    Johnson RJ; Pritzl P; Iida H; Alpers CE
    Am J Pathol; 1991 Feb; 138(2):313-21. PubMed ID: 1704189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation?
    Eng E; Floege J; Young BA; Couser WG; Johnson RJ
    Kidney Int Suppl; 1994 Feb; 45():S45-7. PubMed ID: 8158896
    [No Abstract]   [Full Text] [Related]  

  • 26. [Induction of glomerulonephritis using cultured mesangial cells in rats].
    Ohyama K
    Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):691-702. PubMed ID: 6513159
    [No Abstract]   [Full Text] [Related]  

  • 27. L-Arginine supplementation increases mesangial cell injury and subsequent tissue fibrosis in experimental glomerulonephritis.
    Peters H; Border WA; Noble NA
    Kidney Int; 1999 Jun; 55(6):2264-73. PubMed ID: 10354274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo.
    Daniel C; Wiede J; Krutzsch HC; Ribeiro SM; Roberts DD; Murphy-Ullrich JE; Hugo C
    Kidney Int; 2004 Feb; 65(2):459-68. PubMed ID: 14717916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute glomerular upregulation of ornithine decarboxylase is not essential for mesangial cell proliferation and matrix expansion in anti-Thy-1-nephritis.
    Ketteler M; Westenfeld R; Gawlik A; de Heer E; Distler A
    Nephrol Dial Transplant; 2000 Jan; 15(1):16-22. PubMed ID: 10607762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis.
    Iruela-Arispe L; Gordon K; Hugo C; Duijvestijn AM; Claffey KP; Reilly M; Couser WG; Alpers CE; Johnson RJ
    Am J Pathol; 1995 Dec; 147(6):1715-27. PubMed ID: 7495296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis.
    Hohenstein B; Daniel C; Wagner A; Stasch JP; Hugo C
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F685-93. PubMed ID: 15561976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential role of inflammatory and fibrogenic cytokines in the glomerular diseases.
    Ortiz A; Gómez-Chiarri M; Alonso J; Bustos C; Gómez-Guerrero C; López-Armada MJ; Gómez-Garre D; Palacios I; Ruíz-Ortega M; Gutierrez S
    J Lipid Mediat Cell Signal; 1994 Feb; 9(1):55-74. PubMed ID: 8032716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glomerular nephropathy with mesangial proliferation and acute hepatitis A virus infection. 2 cases].
    Garel D; Vasmant D; Mougenot B; Bensman A
    Ann Pediatr (Paris); 1986 Mar; 33(3):185-8. PubMed ID: 3706993
    [No Abstract]   [Full Text] [Related]  

  • 34. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of TGF-beta in glomerular diseases].
    Okuda S
    Nihon Rinsho; 1992 Dec; 50(12):3032-7. PubMed ID: 1491456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenesis of atherosclerosis and blood platelets: platelet-derived growth factor].
    Okabe T
    Nihon Rinsho; 1988 Mar; 46(3):574-81. PubMed ID: 3404684
    [No Abstract]   [Full Text] [Related]  

  • 37. Suppression of mesangial-cell proliferation by trapidil in glomerulonephritis induced by anti-thymocyte serum in rats.
    Razzaque MS; Cheng M; Taguchi T
    J Int Med Res; 1995; 23(6):458-66. PubMed ID: 8746613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycoplasmal pneumonia associated with mesangiocapillary glomerulonephritis type II (dense deposit disease).
    Von Bonsdorff M; Pönkä A; Törnroth T
    Acta Med Scand; 1984; 216(4):427-9. PubMed ID: 6516912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
    Floege J; Eng E; Young BA; Couser WG; Johnson RJ
    Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-angiogenic compound (TNP-470) inhibits mesangial cell proliferation in vitro and in vivo.
    Haraguchi M; Okamura M; Konishi M; Konishi Y; Negoro N; Inoue T; Kanayama Y; Yoshikawa J
    Kidney Int; 1997 Jun; 51(6):1838-46. PubMed ID: 9186873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.